-
Company Insights
New![]()
Innovation and Patenting activity of Canopy Growth Corp Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Canopy Growth Corp Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
![]()
Omaha Airport – Eppley Glass Canopy and Road Expansion – Nebraska
Equip yourself with the essential tools needed to make informed and profitable decisions with our Omaha Airport – Eppley Glass Canopy and Road Expansion – Nebraska report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Thematic Analysis
![]()
Generation Z in Travel and Tourism – Thematic Intelligence
Gen Z in Travel and Tourism Thematic Report Overview In 2023, Generation Z accounts for people aged between 11 and 26. Asia has the largest Gen Z population at 1.2 billion, followed by the Middle East and Africa with 470 million. This generation uses social media before, during, and after a trip, making it a key component throughout the travel journey. It is increasingly important that destination marketing organizations (DMOs) and travel companies harness this tool as a result. ‘Instagrammable’...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cannabidiol 2 in Autism Spectrum Disorder (ASD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol 2 in Autism Spectrum Disorder (ASD) Drug Details:Cannabidiol is under development for the treatment of pervasive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cannabidiol Isolate in Menstrual Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol Isolate in Menstrual Disorders Drug Details:Cannabidiol isolate is under development for the treatment of menstrual-related symptoms....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Drug Details: ninerafaxstat is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RMC-6236 in Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.RMC-6236 in Colorectal Cancer Drug Details:RMC-6236 is under development for the treatment of solid tumor, colorectal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drug Details:...
-
Sector Analysis
![]()
Jamaica Insurance Industry – Key Trends and Opportunities to 2027
Jamaica Insurance Market Report Overview The gross written premium of the Jamaica insurance market was JMD135 billion ($863.9 million) in 2022. The market is expected to achieve a CAGR of more than 6% during 2023-2027. The Jamaica insurance market research report provides in-depth market analysis, information, and insights into the Jamaica insurance industry. It provides a detailed outlook by product category as well as values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability...
-
Product Insights
![]()
NewcrestImage – New Orleans Canopy by Hilton – Louisiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our NewcrestImage - New Orleans Canopy by Hilton - Louisiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.